HOME >> BIOLOGY >> NEWS
Columbia research to examine gene influence on severity of peridontal disease, therapy response

NEW YORK, NY, September 9, 2004 Scientists at Columbia University Medical Center (CUMC) are looking into the genetic reasons why individuals experience periodontal disease so differently, and why some respond to treatment more successfully than others. Even with treatment, some patients continue to see deterioration of gum condition and eventual loss of teeth.

The research is part of an effort at CUMC to eradicate periodontitis in these patients and better understand how the gum disease develops, and will allow the development of pharmacologic therapies targeted specifically to a person's own genetic predisposition for response.

A new three-year, $1.8 million grant from the National Institute of Dental & Craniofacial Research will support research to determine whether different forms of periodontitis can be classified based on gene expression in inflamed gums.

Periodontitis occurs when infection of the gums goes untreated and inflammation spreads to ligaments and bone that support the teeth. The disease is the leading cause of tooth loss in adults.

Currently, periodontitis is classified into two groups chronic and aggressive that are categorized based on clinical signs after consideration of medical and oral health history. However, distinguishing these two disease categories can be difficult because the clinical signs of both can be quite similar, while response to standard therapeutic procedures may vary considerably. Both types of disease are characterized by swollen gums and deep periodontal pockets. Therapy usually consists of cleaning of the periodontal pockets and root surfaces, accompanied by gum surgery and adjunctive antibiotics.

"The current system for classifying periodontal disease does not have a solid, pathobiology-based foundation," said Panos N. Papapanou, D.D.S., Ph.D., the principal investigator on the project, who is also professor and chair of the Section of Oral and Diagnostic Sciences and dire
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
10-Sep-2004


Page: 1 2

Related biology news :

1. Columbia, Stony Brook, Guidant to develop biological pacemaker based on gene & cell therapies
2. Worlds largest scientific society holds regional meeting in Columbia, Mo.
3. New Columbia Genomic Center of Excellence aims to speed genetic targeting of medicines
4. Columbia offers new ecology program in Dominican Republic
5. Columbia professor receives 2003 National Golden Apple for Teaching Excellence
6. Columbia investigators win 2003 Gairdner International Award for research
7. Gene newly identified by Columbia researchers may improve hair removal
8. Years of research, thought lead geologist to propose new supercontinent Columbia
9. Columbia team finds treatment that corrects cellular defect at the root of heart failure
10. ESA Corporate Award winner 2001: Weyerhaeuser Company Limited British Columbia Coastal Forest Project Team
11. Columbia receives NYSTAR grant - Brain imaging studies will accelerate medical science and create jobs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, ... have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access ... J&J have annual Research and Development spending in excess of US $10 billion. ...
(Date:8/7/2020)... ... 2020 , ... Alucio™, a fast-growing provider of cloud-based software ... Jessica Wong have joined the company’s leadership team as Vice President of Engineering, ... development efforts for Alucio’s flagship product, Beacon, an innovative cloud-based content management and ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval ... CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned a ... The company’s solutions are the first Wharton’s jelly allograft product to be recognized as ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... eSource has long been touted as the solution to high ... eSource, the reasons it did not take off as quickly as people initially expected, ... is moving towards capturing data electronically for clinical trials and then repurposing it for ...
(Date:7/18/2020)... ... 2020 , ... “We are thrilled to deliver this new technology to the ... its kind on the market and we were pleased that the IFT jury recognized ... cultured ingredients, creating a natural way to extend the shelf life and improve the ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... access to competitively procured purchasing contracts to its membership, recently named BioFit ... TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks ...
Breaking Biology Technology:
Cached News: